Nextage Therapeutics Ltd Stock
Stocks
NXTG
IL0004330119
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
TEL AVIV STOCK EXCHANGE
06:44:58 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 39.00 ILa | 0.00% |
|
0.00% | -49.94% |
| Market Cap | 26.25M 0 8.78M 7.52M 7.04M 6.44M 12.09M 840M 12.25M 83.16M 32.43M 422M 32.98M 32.26M 1.4B | P/E 2023 |
-2.52x | P/E 2024 | -7.86x |
|---|---|---|---|---|---|
| Enterprise Value | 26.21M 0 8.77M 7.51M 7.03M 6.43M 12.07M 839M 12.23M 83.02M 32.38M 421M 32.92M 32.21M 1.39B | EV / Sales 2023 |
-
| EV / Sales 2024 | 57.4x |
| Free-Float |
30.21% | Yield 2023 * |
-
| Yield 2024 | - |
| Current month | +2.09% | ||
| 3 months | -17.02% | ||
| 6 months | -49.94% | ||
| Current year | -49.94% |
| 1 week | 39 |  | 40.7 |
| 1 month | 36 | | 42.8 |
| Current year | 6.2 | | 99 |
| 1 year | 6.2 | | 100 |
| 3 years | 6.2 | | 119 |
| 5 years | 6.2 | | 409.4 |
| 10 years | 6.2 | | 600 |
| Manager | Title | Age | Since |
|---|---|---|---|
Abraham Dreazen
CEO | Chief Executive Officer | 42 | 2020-08-11 |
Ishai Gandelsman
DFI | Director of Finance/CFO | 63 | 2022-07-09 |
| General Counsel | 55 | 2020-08-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Israel Makov
CHM | Chairman | 87 | 2011-11-20 |
Ron Grupel
BRD | Director/Board Member | 76 | 2014-10-12 |
Orna Dreazen
BRD | Director/Board Member | 71 | 2020-08-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -52.61% | -42.39% | 4.4M | |
| +2.16% | +5.05% | +99.92% | +310.58% | 4.15B | |
| -7.79% | +18.77% | +208.18% | +29.94% | 3.76B | |
| +1.24% | +2.57% | +36.48% | +62.79% | 3.4B | |
| +3.45% | +7.26% | +274.79% | +480.07% | 2.51B | |
| -3.61% | +3.84% | -21.05% | -21.14% | 2.41B | |
| -0.88% | +16.87% | +27.81% | - | 1.48B | |
| +4.22% | +51.58% | +252.65% | -19.48% | 1.29B | |
| -2.40% | -5.13% | +16.63% | +37.70% | 1B | |
| -2.72% | -2.82% | -36.30% | +0.33% | 552M | |
| Average | -0.63% | +10.09% | +80.65% | +93.16% | 2.06B | |
| Weighted average by Cap. | -0.77% | +10.61% | +113.02% | +145.92% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 876K 0 293K 251K 235K 215K 404K 28.04M 409K 2.78M 1.08M 14.09M 1.1M 1.08M 46.59M | 413K 0 138K 118K 111K 101K 190K 13.22M 193K 1.31M 510K 6.64M 519K 508K 21.97M |
| Net income | -3.88M -0 -1.3M -1.11M -1.04M -952K -1.79M -124M -1.81M -12.29M -4.79M -62.37M -4.87M -4.77M -206M | -3.28M -0 -1.1M -941K -880K -806K -1.51M -105M -1.53M -10.4M -4.06M -52.79M -4.12M -4.03M -175M |
| Net Debt | -101K -0 -33.79K -28.94K -27.08K -24.79K -46.53K -3.23M -47.14K -320K -125K -1.62M -127K -124K -5.37M | -43K -0 -14.39K -12.32K -11.53K -10.55K -19.81K -1.38M -20.07K -136K -53.12K -691K -54.02K -52.84K -2.29M |
Employees
31
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | ILA 39.00 | 0.00% | 100 |
| 26-08-20 | ILA 39.00 | 0.00% | 100 |
| 26-08-19 | ILA 39.00 | 0.00% | 100 |
| 26-08-18 | ILA 39.00 | 0.00% | 100 |
| 26-08-17 | ILA 39.00 | 0.00% | 100 |
- Stock Market
- Stocks
- NXTG Stock
Select your edition
All financial news and data tailored to specific country editions
